NERVGEN PHARMA CORP. Adjustments For Decrease Increase In Trade And Other Receivables
NERVGEN PHARMA CORP. (NGEN) reported Adjustments For Decrease Increase In Trade And Other Receivables of CAD 334.48 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables · last filed 2026-03-31
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|
| 2025-12-31 | 334.48K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | -165.09K CAD 40-F · filed 2026-03-31 |